This 130-page “AI for Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview 2020” report marks the ninth installment in a series of reports on the topic of the Artificial Intelligence application in Drug Discovery industry that Deep Pharma Intelligence have been producing since 2017.

 

The main aim of this series of reports is to provide a comprehensive overview of the industry landscape. This overview highlights AI & Pharma cooperation trends in a form of informative mind maps and infographics as well as benchmarks the performance of key players that form the space and relations within the industry. This is an overview analysis to help the reader understand what is happening in the industry nowadays and possibly give an idea of what is waiting for it in the nearest future.